The escalating tuberculosis crisis in central and South American prisons.
Journal
Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R
Informations de publication
Date de publication:
24 04 2021
24 04 2021
Historique:
received:
15
06
2020
revised:
26
10
2020
accepted:
25
11
2020
pubmed:
12
4
2021
medline:
4
1
2022
entrez:
11
4
2021
Statut:
ppublish
Résumé
In the past decade, tuberculosis incidence has declined in much of the world, but has risen in central and South America. It is not yet clear what is driving this reversal of progress in tuberculosis control. Since 2000, the incarcerated population in central and South America has grown by 206%, the greatest increase in the world. Over the same period, notified tuberculosis cases among the incarcerated population (hereinafter termed persons deprived of their liberty [PDL], following the Inter-American Commission on Human Rights) have risen by 269%. In both central and South America, the rise of disease among PDL more than offsets tuberculosis control gains in the general population. Tuberculosis is increasingly concentrated among PDL; currently, 11% of all notified tuberculosis cases in central and South America occur among PDL who comprise less than 1% of the population. The extraordinarily high risk of acquiring tuberculosis within prisons creates a health and human rights crisis for PDL that also undermines wider tuberculosis control efforts. Controlling tuberculosis in this region will require countries to take urgent measures to prioritise the health of PDL.
Identifiants
pubmed: 33838724
pii: S0140-6736(20)32578-2
doi: 10.1016/S0140-6736(20)32578-2
pmc: PMC9393884
mid: NIHMS1825684
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1591-1596Subventions
Organisme : NIAID NIH HHS
ID : R01 AI130058
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI052073
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests RAL-O serves as Tuberculosis Prevention, Control and Elimination Advisor at the HIV, Hepatitis, Tuberculosis and Sexually Transmitted Infections Unit of the PAHO. MAE is Director of the Department of Communicable Diseases and Environmental Determinants of Health at the PAHO. All other authors declare no competing interests.
Références
Rev Panam Salud Publica. 2016 Jan;39(1):38-43
pubmed: 27754539
Rev Bras Epidemiol. 2011 Sep;14(3):486-94
pubmed: 22069016
Lancet. 2016 Sep 10;388(10049):1089-1102
pubmed: 27427453
Cad Saude Publica. 2015 Jun;31(6):1127-30
pubmed: 26200361
N Engl J Med. 2020 May 28;382(22):2075-2077
pubmed: 32240582
S Afr Med J. 2011 Nov 01;101(11):809-13
pubmed: 22272961
Lancet Public Health. 2021 May;6(5):e300-e308
pubmed: 33765455
Lancet Infect Dis. 2001 Oct;1(3):199-202
pubmed: 11871496
Am J Trop Med Hyg. 2015 Oct;93(4):739-46
pubmed: 26195459
Int J Tuberc Lung Dis. 2014 Nov;18(11):1285-91
pubmed: 25299859
Clin Infect Dis. 2021 Mar 1;72(5):771-777
pubmed: 32064514
Lancet Infect Dis. 2020 Aug;20(8):929-942
pubmed: 32334658
BMC Med. 2018 Aug 3;16(1):122
pubmed: 30071850
Sci Rep. 2018 Jan 17;8(1):997
pubmed: 29343733
Lancet. 2011 Mar 12;377(9769):956-65
pubmed: 21093904
Lancet. 2016 Sep 17;388(10050):1202-14
pubmed: 27427457
Emerg Infect Dis. 2012 Nov;18(11):1802-10
pubmed: 23092584
PLoS Med. 2019 Jan 24;16(1):e1002737
pubmed: 30677013
Emerg Infect Dis. 2015 Mar;21(3):452-5
pubmed: 25642998
Lancet Psychiatry. 2016 Sep;3(9):871-81
pubmed: 27426440